Illés Árpád

1.

Tóthfalusi, D., Dobó, B., Borics, F., Pinczés, L. I., Illés, Á., Miltényi, Z.: Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma.
Clinics and Practice. 15 (1), 1-16, (article identifier: 15), 2025.

doi DEA Scopus

Journal metrics:

Q3 Medicine (miscellaneous) (2023)

2.

Kiss, E., Simon, Z., Illés, Á., Jóna, Á.: Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.
Cancers (Basel). 17 (1), 1-10, (article identifier: 73), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research (2023)

Q1 Oncology (2023)

3.

Obajed, A. A. O., Pfliegler, G., Magyari, F., Borics, F., Pinczés, L. I., Illés, Á., Brúgós, B.: A Case Report of Hyperhemolytic Syndrome in Sickle Cell Disease, with a Special Focus on Avoiding the Use of Transfusions.
Thalass. Rep. 14 (1), 18-25, 2024.

doi DEA WoS

4.

Kenyeres, A., Kiss, E., Simon, Z., Illés, Á., Jóna, Á.: Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma.
J. Int. Med. Res. 52 (2), 1-10, 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry (2023)

Q3 Biochemistry (medical) (2023)

Q4 Cell Biology (2023)

Q3 Medicine (miscellaneous) (2023)

5.

Brúgós, B., Simon, Z., Zsigmond Soós, I., Illés, Á.: A hideg agglutinin betegség diagnosztikája és ellátási gyakorlata.
Hematol. Trasnzfuziol. 57 (3), 209-217, 2024.

doi DEA

6.

Gulyás, A., Pinczés, L. I., Mátyus, J., Végh, E., Bedekovics, J., Tóth, J., Barna, S., Hunya, Z., Szabó, I. L., Gazdag, A., Illés, Á., Magyari, F.: Case report: targeted treatment strategies for Erdheim-Chester disease.
Front Oncol. 14, 1-6, (article identifier: 1305518), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research (2023)

Q2 Oncology (2023)

7.

Brúgós, B., Simon, Z., Méhes, G., Illés, Á., Pfliegler, G.: Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary.
Pathol. Oncol. Res. 30, 1-10, (article identifier: 1611785), 2024.

doi DEA WoS

Journal metrics:

Q3 Cancer Research (2023)

Q2 Medicine (miscellaneous) (2023)

Q2 Oncology (2023)

Q2 Pathology and Forensic Medicine (2023)

8.

Bicskó, R. R., Illés, Á., Hevessy, Z., Ivády, G., Kerekes, G., Méhes, G., Csépány, T., Gergely, L.: Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis.
Hematol Rep. 16 (2), 255-259, 2024.

doi DEA WoS Scopus

Journal metrics:

Q4 Hematology (2023)

9.

Németh, R., Bicskó, R. R., Illés, Á., Gergely, L.: Epstein-Barr-vírus által indukált hemolízis diffúz nagy B-sejtes limfómában.
Hematol. Trasnzfuziol. 56 (4), 194-198, 2024.

doi DEA

10.

Roboz, G. J., Sanz, G., Griffiths, E. A., Yee, K., Kantarjian, H., Récher, C., Byrne, M. T., Patkowska, E., Kim, H. J., Thomas, X., Moors, I., Stock, W., Illés, Á., Fenaux, P., Miyazaki, Y., Yamauchi, T., O'Connell, C. L., Hao, Y., Keer, H. N., Azab, M., Döhner, H.: Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.
Blood Adv. 8 (8), 2020-2029, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology (2023)

11.

Pratz, K. W., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Döhner, H., Recher, C., Fiedler, W., Yamamoto, K., Wang, J., Yoon, S. S., Wolach, O., Yeh, S. P., Leber, B., Esteve, J., Mayer, J., Porkka, K., Illés, Á., Lemoli, R. M., Turgut, M., Ku, G., Miller, C., Zhou, Y., Zhang, M., Chyla, B., Potluri, J., DiNardo, C. D.: Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am. J. Hematol. 99 (4), 615-624, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology (2023)

12.

Gupta, V., Oh, S. T., Devos, T., Dubruille, V., Catalano, J., Somervaille, T. C. P., Platzbecker, U., Giraldo, P., Kosugi, H., Sacha, T., Mayer, J., Illés, Á., Ellis, C., Wang, Z., Gonzalez Carreras, F. J., Strouse, B., Mesa, R.: Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.
Leuk. Lymphoma. 65 (7), 965-977, 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2023)

Q2 Hematology (2023)

Q2 Oncology (2023)

13.

Woyach, J. A., Jones, D., Jurczak, W., Robak, T., Illés, Á., Kater, A. P., Ghia, P., Byrd, J. C., Seymour, J. F., Long, S., Mohamed, N., Benrashid, S., Lai, T. H., Jesus, G. D., Lai, R., Bruin, G. d., Rule, S., Munugalavadla, V.: Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Blood. [Epub ahead of print], 2024.

doi DEA Scopus

Journal metrics:

D1 Biochemistry (2023)

D1 Cell Biology (2023)

D1 Hematology (2023)

D1 Immunology (2023)

14.

Bojtor, C., Nagy, J., Széles, A., Harsányi, E., Ssemugenze, B., Ocwa, A., Illés, Á.: Nitrogen use efficiency of maize in different fertilisation levels based on long-term field experiment.
In: 2nd International Congress on Sustainable Development in the Human Environment - Current and Future Challenges : Proceedings book. Eds.: Atilgan Atilgan, Infrastructure and Ecology of Rural Areas Association, Antalya, 33, 2024. ISBN: 9786258254600

DEA

15.

Virga, B., Pinczés, L. I., Illés, Á., Miltényi, Z., Magyari, F., Méhes, G., Simon, Z.: Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: a Single-Centre Experience.
Cureus. 16 (6), 1-10, (article identifier: 63307), 2024.

doi DEA WoS

16.

Kiladjian, J. J., Marin, F. F., Al-Ali, H. K., Illés, Á.: ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann. Hematol. 103 (7), 2299-2310, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology (2023)

Q1 Medicine (miscellaneous) (2023)

17.

Obajed Al-Ali, N., Pinczés, L. I., Farkas, K., Kerekes, G., Illés, Á., Váróczy, L.: Steady-State Versus Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma: a Single-Center Study to Analyze Efficacy and Safety.
J. Hematol. 13 (3), 79-85, 2024.

doi DEA

18.

Pinczés, L. I., Jóna, Á., Mezei, G., Kenyeres, A., Vekszler, P. P., Illés, Á., Simon, Z.: Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis.
Ann. Hematol. 2024, 1-3, 2024.

doi DEA WoS Scopus

19.

Illés, Á., Dobó, B., Borics, F., Tóthfalusi, D., Pinczés, L. I., Miltényi, Z.: The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin's Lymphoma Patients (1980-2019).
Medicina (Kaunas). 60 (8), 1-15, (article identifier: 1272), 2024.

doi DEA Scopus

Journal metrics:

Q2 Medicine (miscellaneous) (2023)

20.

Bicskó, R. R., Nyilas, R., Szász, R., Váróczy, L., Kiss, A., Udvardy, M., Illés, Á., Gergely, L.: The efficacy and safety of second salvage autologous transplantation in myeloma patients.
Pathol. Oncol. Res. 30, 1-7, (article identifier: 1611851), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2023)

Q2 Medicine (miscellaneous) (2023)

Q2 Oncology (2023)

Q2 Pathology and Forensic Medicine (2023)

21.

Gergely, L., Udvardy, M., Illés, Á.: The Possible Role of Pathogens and Chronic Immune Stimulation in the Development of Diffuse Large B-Cell Lymphoma.
Biomedicines. 12 (3), 1-19, (article identifier: 648), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)

Q1 Medicine (miscellaneous) (2023)

22.

Márton, A., Veres, K. B., Erdődi, F., Udvardy, M., Illés, Á., Rejtő, L.: The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.
Pathol. Oncol. Res. 30, 1-19, (article identifier: 1611747), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2023)

Q2 Medicine (miscellaneous) (2023)

Q2 Oncology (2023)

Q2 Pathology and Forensic Medicine (2023)

23.

Illés, Á.: A Hodkgin lymphoma utolsó negyedszázada, ahogy én látom.
Focus Med. 35 (3), 19-20, 2023.

DEA

24.

Lovas, S., Gergely, L., Illés, Á., Váróczy, L.: A plasmoblastos lymphoma kezelésének bemutatása három eset kapcsán.
Hematol. Trasnzfuziol. Különszám, 56, 2023.

doi DEA

25.

Karádi, É., Dombi, P., Győriné, K. V., Kovács, E., Herczeg, J., Andrikovics, H., Illés, Á., Demeter, J., Homor, L., Udvardy, M., Egyed, M.: A potentially new thromboembolic event scoring system in polycythaemia vera patients: an audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia register.
Eur. J. Haematol. 111 (2), 263-270, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

Q1 Medicine (miscellaneous)

Publication list